Application of a Double Aza-Michael Reaction in a ‘Click, Click, Cy-Click’ Strategy: From Bench to Flow by Zang, Qin et al.
SPECIAL TOPIC 2743
Application of a Double Aza-Michael Reaction in a ‘Click, Click, Cy-Click’ 
Strategy: From Bench to Flow 
Double Aza-Michael ‘Click, Click, Cy-Click’ Strategy: Bench to FlowQin Zang,a Salim Javed,a Farman Ullah,b Aihua Zhou,a Christopher A. Knudtson,a Danse Bi,a Fatima Z. Basha,c 
Michael G. Organ,*b Paul R. Hanson*a
a Department of Chemistry, University of Kansas, 1251 Wescoe Hall Drive, Lawrence, KS 66045-7582 
and the Center for Chemical Methodologies and Library Development at the University of Kansas (KU-CMLD), 
2034 Becker Drive, Delbert M. Shankel Structural Biology Center, Lawrence, KS 66047-3761, USA
Fax +1(785)8645396; E-mail: phanson@ku.edu
b Department of Chemistry, York University, 4700 Keele Street, Toronto, ON, M3J 1P3, Canada
Fax +1(416)7365936; E-mail: organ@yorku.ca
c H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological SciencesUniversity of Karachi, Pakistan
Received 18 March 2011
SYNTHESIS 2011, No. 17, pp 2743–2750xx.xx.2011
Advanced online publication: 14.07.2011
DOI: 10.1055/s-0030-1260112; Art ID: C30911SS
© Georg Thieme Verlag Stuttgart · New York
Abstract: The development of a ‘click, click, cy-click’ process uti-
lizing a double aza-Michael reaction to generate functionalized
1,2,5-thiadiazepane 1,1-dioxides is reported. Optimization in flow,
followed by scale out of the inter-/intramolecular double aza-
Michael addition has also been realized using a microwave-assisted,
continuous flow organic synthesis platform (MACOS). In addition,
a facile one-pot, sequential strategy employing in situ Huisgen cy-
cloaddition post-double aza-Michael has been accomplished, and is
applicable to library synthesis.
Key words: double-aza-Michael, click, MACOS, flow, 1,2,5-thia-
diazepane 1,1-dioxides
The development of facile, step-efficient methods to ac-
cess new heterocycles is a key component in the drug-dis-
covery process. Hetero-Michael reactions are efficient
pathways that, historically, have been broadly used in syn-
thesis, including several intramolecular examples to ac-
cess a variety of heterocycles, namely, dioxolanes en
route to 1,3-diols,1 azacycles,2 oxacycles,3 thiacycles,4
and bis-heterocycles.5 Recently, double aza-Michael reac-
tions have been utilized as efficient means to install two
N–C bonds in a single operation.6 Herein, we report a new
approach termed ‘click, click, cy-click’ that utilizes two
click reactions7 and a double aza-Michael reaction for the
facile synthesis of 1,2,5-thiadiazepane 1,1-dioxides. Opti-
mization using a microwave-assisted continuous flow
synthetic (MACOS) platform, has transformed the non-
click cyclization step into a facile one-minute (resident
flow time) cyclization event (cy-click) that has also been
scaled out.
Although not found in nature, sultams have emerged as
privileged structures due to their extensive chemical and
biological profiles.8,9 Recently, a number of reports of sul-
tams have appeared demonstrating broad-spectrum bioac-
tivity. Such reports include anti-HIV activity,10
antidepressant activity,11 and as inhibitors of RSV,12 se-
lective tumor necrosis factor,13 and metalloproteinase.14
Previously, the inherent reactivity of vinyl sulfonamides
was utilized in a ‘click, click, cyclize’ strategy for the fac-
ile construction of diverse sultam scaffolds via intramo-
lecular oxa- and intermolecular aza-Michael reactions
(Scheme 1, pathway a).3i,15 At the heart of this approach is
the facile production of precursor tertiary vinyl sulfon-
amides by the use of two click reactions,7 namely, sulfon-
ylation of in situ generated vinyl sulfonyl chloride,
followed by alkylation of the resulting 2° sulfonamide and
subsequent cyclization. 
In this new report outlined in Scheme 1 (pathways b and
c), an inter-/intramolecular double aza-Michael pathway



















































































2744 Q. Zang et al. SPECIAL TOPIC
Synthesis 2011, No. 17, 2743–2750 © Thieme Stuttgart · New York
serves as the cyclization step in a ‘click, click, cy-click’
sequence, and utilizes a TBS-protected serinol methyl es-
ter in the initial sulfonylation step. Subsequent alkylation,
followed by a one-pot, b-elimination/double aza-Michael
reaction yields functionalized 1,2,5-thiadiazepane 1,1-di-
oxide scaffolds.
Overall, this facile approach utilizes the b-elimination of
the alcohol in the serine-moiety present in 2 to generate a
second Michael acceptor armed for the titled protocol.
This later sequence has its roots in the biosynthesis of
tryptophan, which utilizes tryptophan synthase, a pyri-
doxal phosphate-containing bifunctional enzyme (PLP),
to catalyze an elimination/indole addition pathway on
serine.16 Taken collectively, the route employs two click
reactions and a double aza-Michael cyclization step that is
optimized using a MACOS platform17 (cy-click).
Initial efforts focused on the preparation of vinyl sulfona-
mide 3, obtained in a simple three-step sequence from
serine methyl ester (Scheme 2). Racemic serine methyl
ester was protected as a TBS-ether,18 to which 2-chloro-
ethanesulfonyl chloride was added, providing 2, which
was subsequently benzylated under mild conditions to
provide 3. A facile pathway to 5 was next envisioned to
proceed via elimination of the TBS-ether moiety19,20 to
generate 4, followed by a double aza-Michael reaction of
an amine. Towards this goal, treatment of 3 with TBAF in
tetrahydrofuran, in the absence of nucleophile, resulted in
the production of elimination product 4 in 30% yield. Use
of cesium carbonate in acetonitrile further promoted the
elimination pathway to yield 4 in 91%. Addition of cyclo-
pentylamine to 4 in acetonitrile gave 5 in moderate yield
(Scheme 2). 
Further studies showed that while 4 can be isolated, a one-
pot operation consisting of adding base and cyclopentyl-
amine to a stirring solution of 3, directly afforded the dou-
ble aza-Michael product 5a (Table 1). Optimization of
various parameters, including solvent, temperature and
base (equiv), revealed that cesium carbonate in acetoni-
trile at 40 °C gave nice conversion (Table 1, entries 1–6).
However, use of 1,8-diazabicyclo[5.4.0]undec-7-ene
(DBU) as base (Table 1, entries 7–10) improved the yield
significantly, with optimized conditions established using



























CH2Cl2, r.t., 12 h
Cl
over three steps:
3a R1 =  Me, 90% 
3b R1 =  OMe, 92%
3c R1 = H, 82%
3d R1 = Cl, 85% 
3e R1 = F, 60% 



















Table 1 Optimization of One-Pot Elimination and Double Aza-
Michael Reactiona
Entry Base Temp, time Solvent Yield (%)b
1 Cs2CO3
(1 equiv)
40 °C, 12 h MeCN 50
2 Cs2CO3
(1 equiv)
40 °C, 12 h CH2Cl2 44
3 Cs2CO3
(1 equiv)
40 °C, 12 h MeOH 0
4 Cs2CO3
(1 equiv)
60 °C, 12 h MeCN 43
5 Cs2CO3
(2 equiv)
60 °C, 12 h MeCN 32
6 Cs2CO3
(1 equiv)
40 °C, 12 h DMF 42
7 DBU
(0.5 equiv)
r.t., 12 h MeCN 23
8 DBU
(0.1 equiv)
40 °C, 1 h DMF 30
9 DBU
(0.1 equiv)
r.t., 12 h MeOH 69
10 DBU
(0.1 equiv)
40 °C, 1 h MeOH 75
a A solution of compound 3a (1 equiv) and cyclopentylamine (1.1 
equiv) in solvent (0.1 M) was added base and stirred at the indicated 
temperature and time.
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0.1 equivalent of DBU in methanol at 40 °C for one hour
(entry 10). 
With the optimized conditions in hand, a demonstration
set of 1,2,5-thiadiazepane 1,1-dioxides were synthesized
using linear (Table 2, entries 1, 2, 5, and 6) as well as ben-
zylamines (Table 2, entries 3, 4, and 7). Within the ali-
phatic amines, several linear amines worked well. Not
surprisingly, more sterically encumbered tert-butylamine
failed to undergo the double aza-Michael reaction, but in-
stead simple Michael addition of methanol was obtained
in roughly 40% yield.
In efforts to utilize the double aza-Michael strategy in li-
brary synthesis, it was deemed imperative that the scaf-
fold be synthesized efficiently and quickly on a larger
scale. This seemed achievable by combining microwave
heating and flow chemistry using the MACOS (micro-
wave-assisted, continuous-flow organic synthesis) plat-
form. Using this synthetic technique, one set of
optimization experiments is all that is necessary to obtain,
and in theory, any amount of desired product can be gen-
erated by scaling the synthesis out, rather than scaling it
up, which involves extensive reaction reoptimization at
each growing scale in the process. 
The optimal bench conditions in Table 1 (entry 10) were
initially employed in MACOS, resulting in a mixture with
the mono aza-Michael product as the major component. A
more complex product mixture was obtained when addi-
tional heat was applied in order to push the reaction in
methanol. Use of higher-boiling n-butanol did provide the
double aza-Michael product, but transesterification was
also observed (5–15%). This problem was circumvented
by the use of propan-2-ol leading to products 5a and 5c in
60% (0.5 g) and 71% (0.7 g), respectively (Table 2, en-
tries 8 and 9). These proof-of-concept experiments illus-
Table 2 Synthesis of 1,2,5-Thiadiazepane 1,1-Dioxides
Entry R1 R2 Product Yield (%)
1 MeO n-C8H17 5b 65
2 H n-Bu 5c 74
3 H 4-FC6H4CH2 5d 69
4 Cl 4-MeOC6H4CH2 5e 82
5 Cl PhCH2CH2 5f 77
6 F i-Bu 5g 65
7 CF3 Bn 5h 79
8a Me c-C5H9 5aa 60a
9a H n-Bu 5ca 71a
a Performed using the following MACOS conditions: 3a/3c (1.0 
equiv), DBU (1.0 equiv), amine (1.2 equiv), i-PrOH (0.3 M), 75 mL/
min, 100 °C, 130 W.
Table 3 Sequential, One-Pot Elimination, Double Aza-Michael and Huisgen 1,3-Dipolar Cycloaddition
Entry R1 R2 Product Yield (%)
1 n-Bu 4-MeC6H4CH2 7a 61
2 n-Bu 3-ClC6H4CH2 7b 65
3 n-Bu 2-BrC6H4CH2 7c 73
4 Bn 4-MeC6H4CH2 7d 83
5 Bn 3-ClC6H4CH2 7e 65
6 Bn 2-BrC6H4CH2 7f 74
7 HOCH2CH2 4-MeC6H4CH2 7g 81
8 HOCH2CH2 3-ClC6H4CH2 7h 87
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trate that we can obtain any amount of product we require
for library elaboration using scale-out in MACOS.
Successes with the double aza-Michael reaction led us to
explore a sequential, one-pot process employing an addi-
tional in situ Huisgen 1,3-dipolar cycloaddition click reac-
tion, to terminate the route.21 The propargyl-substituted
sulfonamide was synthesized in 79% yield (over three
steps) using potassium carbonate in the presence of sodi-
um iodide in N,N-dimethylformamide. The double aza-
Michael reaction was performed using the optimal bench
conditions (Table 1, entry 10), and the resultant mixture
was concentrated in the reaction vial and reconstituted in
dichloromethane, after which the azide and copper(I) io-
dide were added, and stirred at room temperature for 16
hours. Efforts aimed at simplifying the procedure by using
same solvent for both double aza-Michael and Huisgen
cycloaddition reactions, either gave a lower yield (in
CH2Cl2) or multiple products (in MeOH). While addition-
al efforts continue toward this goal, a set of reactions was
carried out using a sequential, one-pot procedure to afford
the desired products in good yields (Table 3).
In conclusion, we have developed a double aza-Michael
procedure using MACOS to synthesize 1,2,5-thiadiaze-
pane 1,1-dioxides that involves minimal chromatography
and is step-efficient. Application of flow chemistry for
optimization and scale-out sets the stage for library syn-
thesis. Further investigations have led to a sequential, one-
pot elimination, double aza-Michael and Huisgen
cycloaddition for the synthesis of triazolated 1,2,5-
thiadiazepane 1,1-dioxides. Subsequent research will be
focused on library synthesis using this protocol. All com-
pounds synthesized have been submitted to the NIH Mo-
lecular Library Small Molecule Repository (MLSMR) for
distribution within the MLSCN, which will allow for ex-
tensive biological screening.
All reactions were carried out without inert atmosphere. Stirring
was achieved with oven-dried magnetic stir bars. Solvents were ei-
ther purchased through Sigma-Aldrich or purified by passage
through the Solv-Tek purification system employing activated
Al2O3.
22 Et3N was purified by passage over basic Al2O3 or distilled
over CaH2 and stored over KOH. Flash column chromatography
was performed with Sorbent Technologies (30930M-25, Silica Gel
60A, 40–63 mm). TLC was performed on silica gel 60F254 plates
(EM-5717, Merck). Deuterated solvents were purchased from Cam-
bridge Isotope laboratories. 1H, 13C NMR spectra were recorded on
a Bruker DRX-400 spectrometer operating at 400 MHz, 100 MHz,
respectively, as well as a Bruker DRX-500 spectrometer operating
at 500 MHz, 125 MHz, respectively, and a Avance AV-III 500 with
a dual carbon/proton (CPDUL) cryoprobe operating at 500 MHz,
125 MHz, respectively. High-resolution mass spectrometry
(HRMS) measurements were obtained on a VG Instrument ZAB
double-focusing mass spectrometer.
Generation of 1,2,5-Thiadiazepane 1,1-Dioxides 5 via Double 
Aza-Michael on Bench; General Procedure
To the tertiary sulfonamide 3 (0.2 mmol, 1 equiv) was added MeOH
(0.1 M), amine (0.22 mmol, 1.1 equiv), and DBU (0.04 mmol, 0.2
equiv). The solution was stirred at 40 °C for 1 h, the solvent was
evaporated and the crude product was purified by flash column
chromatography on silica gel (hexane–EtOAc, 3:1).
Methyl 5-Cyclopentyl-2-(4-methylbenzyl)-1,2,5-thiadiazepane-
3-carboxylate 1,1-Dioxide (5a)
Yield: 57 mg (75%); colorless oil.
FTIR (thin film): 2951, 2866, 1734, 1329, 1142 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.29 (d, J = 8.0 Hz, 2 H), 7.15 (d,
J = 7.8 Hz, 2 H), 4.79 (d, J = 15.0 Hz, 1 H), 4.31 (d, J = 15.0 Hz, 1
H), 3.94–3.86 (m, 1 H), 3.60 (s, 3 H), 3.45 (s, 1 H), 3.43 (d, J = 3.3
Hz, 1 H), 3.23 (d, J = 4.3 Hz, 1 H), 3.22 (d, J = 4.1 Hz, 1 H), 3.11
(ddd, J = 14.8, 4.1, 4.1 Hz, 1 H), 3.01 (ddd, J = 14.7, 6.7, 6.7 Hz, 1
H), 2.76–2.67 (m, 1 H), 2.35 (s, 3 H), 1.67 (m, 4 H), 1.48–1.38 (m,
2 H), 1.35–1.20 (m, 2 H).
13C NMR (126 MHz, CDCl3): d = 170.6, 137.8, 132.8, 129.2, 129.0,
63.3, 57.0, 55.0, 54.6, 53.6, 52.3, 48.7, 30.8, 30.2, 23.6, 23.5, 21.1.





Yield: 57 mg (65%); colorless oil.
FTIR (thin film): 2951, 2928, 2854, 1736, 1514, 1329, 1248, 1142
cm–1.
1H NMR (500 MHz, CDCl3): d = 7.34–7.29 (m, 2 H), 6.90–6.84 (m,
2 H), 4.67 (d, J = 14.9 Hz, 1 H), 4.34 (d, J = 14.9 Hz, 1 H), 3.90 (dd,
J = 10.5, 6.5 Hz, 1 H), 3.81 (s, 3 H), 3.57 (s, 3 H), 3.47 (dd, J = 14.7,
10.6 Hz, 1 H), 3.36 (dd, J = 14.7, 6.5 Hz, 1 H), 3.26–3.22 (m, 2 H),
3.02 (dd, J = 7.8, 3.9 Hz, 2 H), 2.46–2.40 (m, 2 H), 1.41–1.17 (m,
12 H), 0.90 (t, J = 7.0 Hz, 3 H).
13C NMR (126 MHz, CDCl3): d = 170.5, 159.4, 130.4, 127.8, 113.8,
57.1, 55.8, 55.3, 55.3, 54.8, 53.3, 52.3, 50.0, 31.8, 29.4, 29.3, 27.7,
27.1, 22.7, 14.1.





Yield: 53 mg (74%); light yellow solid; mp 58 °C.
FTIR (thin film): 2954, 2931, 2869, 1737, 1454, 1330, 1143, 1072,
744, 703 cm–1. 
1H NMR (300 MHz, CDCl3): d = 7.38–7.36 (m, 2 H), 7.32–7.27 (m,
3 H), 4.72 (d, J = 15.3 Hz, 1 H), 4.32 (d, J = 15.0 Hz, 1 H), 3.93 (m,
1 H), 3.49 (s, 3 H), 3.43–3.27 (m, 2 H), 3.22–3.20 (m, 2 H), 2.99 (m,
2 H), 2.44 (t, J = 7.2 Hz, 2 H), 1.37–1.32 (m, 2 H), 1.26–1.21 (m, 2
H), 0.89 (t, J = 7.2 Hz, 3 H).
13C NMR (75 MHz, CDCl3): d = 170.3, 135.9, 128.9, 128.4, 127.9,
57.4, 55.8, 55.2, 54.7, 53.7, 52.1, 49.3, 29.8, 20.1, 13.9.





Yield: 56 mg (69%); yellow oil.
FTIR (thin film): 2951, 2843, 1732, 1508, 1329, 1219, 1142, 771,
743, 704 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.44–7.35 (m, 5 H), 7.10–7.05 (m,
2 H), 7.02–6.94 (m, 2 H), 4.94 (d, J = 15.1 Hz, 1 H), 4.32 (d,
J = 15.1 Hz, 1 H), 3.86 (dd, J = 10.5, 6.6 Hz, 1 H), 3.59–3.55 (m, 1
H), 3.57 (s, 3 H), 3.52–3.46 (m, 2 H), 3.34 (dd, J = 14.7, 6.6 Hz, 1
H), 3.25–3.22 (m, 2 H), 3.04–2.96 (m, 2 H).
13C NMR (126 MHz, CDCl3): d = 170.2, 162.1 (d, 1JC,F = 245.9 Hz),
135.9, 133.7 (d, 4JC,F = 3.1 Hz), 129.9 (d, 
3JC,F = 8.0 Hz), 129.3,
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Yield: 74 mg (82%); yellow oil.
FTIR (thin film): 2951, 2932, 2837, 1736, 1610, 1512, 1329, 1246,
1144, 1078, 1014, 837, 741 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.36 (s, 4 H), 7.10 (d, J = 8.6 Hz,
2 H), 6.86 (d, J = 8.7 Hz, 2 H), 4.77 (d, J = 15.3 Hz, 1 H), 4.36 (d,
J = 15.3 Hz, 1 H), 3.88 (dd, J = 10.4, 6.7 Hz, 1 H), 3.82 (s, 3 H),
3.66 (d, J = 12.4 Hz, 1 H), 3.58 (d, J = 13.0 Hz, 1 H), 3.53 (s, 3 H),
3.45 (dd, J = 14.4, 10.5 Hz, 1 H), 3.32 (dd, J = 14.5, 6.6 Hz, 1 H),
3.25–3.14 (m, 2 H), 3.03–2.90 (m, 2 H).
13C NMR (126 MHz, CDCl3): d = 170.0, 159.0, 134.6, 133.9, 130.4,
130.0, 129.7, 128.7, 113.9, 60.6, 57.7, 55.9, 55.3, 54.8, 52.9, 52.3,
49.5.





Yield: 67 mg (77%); yellow oil.
FTIR (thin film): 2951, 2930, 2847, 1738, 1491, 1331, 1142, 1082,
1014, 752, 739, 700 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.36–7.30 (m, 2 H), 7.30–7.22 (m,
5 H), 7.19–7.14 (m, 2 H), 4.31 (d, J = 15.4 Hz, 1 H), 4.23 (d,
J = 15.4 Hz, 1 H), 3.91 (dd, J = 10.5, 6.7 Hz, 1 H), 3.51 (s, 3 H),
3.48 (dd, J = 14.5, 10.6 Hz, 1 H), 3.39 (dd, J = 14.5, 6.7 Hz, 1 H),
3.24–3.19 (m, 2 H), 3.12–2.99 (m, 2 H), 2.95–2.83 (m, 2 H), 2.81–
2.73 (m, 2 H).
13C NMR (126 MHz, CDCl3): d = 170.0, 139.4, 134.5, 133.7, 130.2,
128.6, 128.6, 128.5, 126.4, 58.2, 57.9, 56.2, 54.3, 52.9, 52.3, 49.9,
34.4.





Yield: 48 mg (65%); colorless oil.
FTIR (thin film): 2955, 2870, 1738, 1510, 1329, 1221, 1146, 1078,
754 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.62–7.32 (m, 2 H), 7.19–6.91 (m,
2 H), 4.69 (d, J = 15.1 Hz, 1 H), 4.38 (d, J = 15.1 Hz, 1 H), 3.92 (dd,
J = 10.6, 6.5 Hz, 1 H), 3.55 (s, 3 H), 3.48 (dd, J = 14.7, 10.7 Hz, 1
H), 3.33 (dd, J = 14.7, 6.5 Hz, 1 H), 3.28–3.22 (m, 2 H), 3.04–2.99
(m, 2 H), 2.28–2.18 (m, 2 H), 1.68–1.62 (m, 1 H), 0.86 (d, J = 6.6
Hz, 6 H).
13C NMR (126 MHz, CDCl3): d = 170.2, 162.5 (d, 1JC,F = 246.7 Hz),
131.8 (d, 4JC,F = 3.2 Hz), 130.7 (d, 
3JC,F = 8.2 Hz), 115.4 (d,
2JC,F = 21.5 Hz), 63.9, 57.4, 56.5, 54.9, 53.0, 52.3, 50.4, 26.8, 20.5,
20.5.





Yield: 72 mg (79%); yellow oil.
FTIR (thin film): 2953, 2930, 2843, 1740, 1325, 1163, 1144, 1122,
1067, 735, 700 cm–1.
1H NMR (500 MHz, CDCl3): d = 7.64 (d, J = 8.1 Hz, 2 H), 7.56 (d,
J = 8.1 Hz, 2 H), 7.36–7.28 (m, 3 H), 7.25–7.21 (m, 2 H), 4.85 (d,
J = 15.6 Hz, 1 H), 4.47 (d, J = 15.6 Hz, 1 H), 3.95 (dd, J = 10.4, 6.6
Hz, 1 H), 3.77 (d, J = 13.2 Hz, 1 H), 3.69 (d, J = 13.2 Hz, 1 H), 3.50
(s, 3 H), 3.49 (dd, J = 14.4, 10.5 Hz, 1 H), 3.35 (dd, J = 14.4, 6.6 Hz,
1 H), 3.29–3.19 (m, 2 H), 3.08–2.94 (m, 2 H).
13C NMR (126 MHz, CDCl3): d = 169.8, 140.3, 138.0, 130.2 (q,
2JC,F = 32.5 Hz), 129.1, 128.6, 128.5, 127.8, 126.2 (q, 
1JC,F = 272.1
Hz), 125.4 (q, 3JC,F = 3.7 Hz), 61.6, 58.0, 56.1, 54.7, 52.9, 52.3,
49.7.
HRMS (TOF MS ES+): m/z calcd for C21H24F3N2O4S (M + H)
+:
457.1409; found: 457.1406.
Scale-Out Synthesis of 1,2,5-Thiadiazepane 1,1-Dioxides 5a and 
5c Utilizing MACOS Flow Platform; General Procedure
A stock solution containing the respective sulfonamide 3a, 3c (2.4
or 2.8 mmol, 1.0 equiv), DBU (2.4 or 2.8 mmol, 1.0 equiv), and
amine (2.8 or 3.3 mmol, 1.2 equiv) in i-PrOH (0.3 M) was prepared
and loaded into Hamilton gas-tight syringe (10 mL). The tubing was
primed with i-PrOH and the syringe was connected to the reactor
system with the aid of MicrotightTM fittings. A sealed collection vial
was connected to the system, where a pressurized airline (75 psi)
was attached to create backpressure. A Harvard 22 syringe pump
was set to deliver the reaction solution at a rate of 75 mL/min. The
single mode microwave was programmed to heat constantly with
the power level controlled manually so as to keep the temperature
constant at the specified levels (130 W, ~100 °C). The effluent from
the reactor was fed into a sealed vial and analyzed directly by 1H
NMR spectroscopy immediately after the reaction. The crude reac-
tion mixture was collected and the product was purified by flash
chromatography (EtOAc–n-pentane, 2:8) to afford the desired sul-
tam 5a (534 mg, 60%, greenish oil) and 5c (700 mg, 71%, light yel-
low solid).
Triazolated 1,2,5-Thiadiazepane 1,1-Dioxides 7; General Proce-
dure
To the tertiary sulfonamide 6 (0.2 mmol, 1 equiv) was added MeOH
(0.1 M), amine (0.24 mmol, 1.2 equiv), and DBU (0.04 mmol, 0.2
equiv). The solution was stirred at 40 °C for 1 h. The solvent was
removed under a Techne sample concentrator. The residue was fur-
ther dried under high vacuum pump for 2 h. To the residue was add-
ed CH2Cl2 (0.1 M), azide (0.4 mmol, 2 equiv), CuI (0.04 mmol, 0.2
equiv) and stirred overnight. The solvent was removed under a
Techne sample concentrator and the crude product was purified by
flash column chromatography on silica gel (hexane–EtOAc, 2:1).
Methyl 5-Butyl-2-{[1-(4-methylbenzyl)-1H-1,2,3-triazol-4-
yl]methyl}-1,2,5-thiadiazepane-3-carboxylate 1,1-Dioxide (7a)
Yield: 45 mg (61%); yellow oil.
FTIR (thin film): 2953, 2930, 1747, 1329, 1144, 779, 758 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.61 (s, 1 H), 7.18 (s, 4 H), 5.47
(s, 2 H), 4.74 (d, J = 15.9 Hz, 1 H), 4.50 (d, J = 15.9 Hz, 1 H), 4.08
(t, J = 8.5 Hz, 1 H), 3.54 (s, 3 H), 3.43 (d, J = 8.6 Hz, 2 H), 3.24–
3.13 (m, 2 H), 3.07–2.93 (m, 2 H), 2.52–2.39 (m, 2 H), 2.35 (s, 3 H),
1.43–1.33 (m, 2 H), 1.33–1.20 (m, 2 H),  0.91 (t, J = 7.2 Hz, 3 H).
13C NMR (126 MHz, CDCl3): d = 170.3, 144.2, 138.7, 131.5, 129.8,
128.1, 123.2, 58.2, 55.8, 54.7, 54.4, 54.0, 52.2, 49.8, 45.7, 29.8,
21.1, 20.2, 13.9.





Yield: 51 mg (65%); colorless oil.
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1H NMR (400 MHz, CDCl3): d = 7.70 (s, 1 H), 7.37–7.29 (m, 2 H),
7.25 (s, 1 H), 7.18–7.15 (m, 1 H), 5.50 (s, 2 H), 4.73 (d, J = 15.9 Hz,
1 H), 4.54 (d, J = 15.9 Hz, 1 H), 4.11 (t, J = 8.5 Hz, 1 H), 3.57 (s, 3
H), 3.46–3.40 (m, 2 H), 3.19 (t, J = 5.2 Hz, 2 H), 3.05–2.96 (m, 2
H), 2.56–2.43 (m, 2 H), 1.46–1.35 (m, 2 H), 1.34–1.22 (m, 2 H),
0.92 (t, J = 7.3 Hz, 3 H).
13C NMR (126 MHz, CDCl3): d = 170.2, 144.7, 136.6, 135.0, 130.4,
129.0, 128.0, 126.0, 123.5, 58.5, 55.8, 54.9, 54.4, 53.5, 52.3, 49.8,
45.8, 29.8, 20.2, 14.0.





Yield: 63 mg (73%); yellow oil.
FTIR (thin film): 2953, 2930, 2860, 1747, 1329, 1144, 756 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.73 (s, 1 H), 7.62 (dd, J = 7.9, 1.1
Hz, 1 H), 7.32 (td, J = 7.5, 1.2 Hz, 1 H), 7.24 (td, J = 7.8, 1.8 Hz, 1
H), 7.18 (dd, J = 7.6, 1.5 Hz, 1 H), 5.66 (s, 2 H), 4.78 (d, J = 15.9
Hz, 1 H), 4.52 (d, J = 15.9 Hz, 1 H), 4.11 (t, J = 8.5 Hz, 1 H), 3.59
(s, 3 H), 3.44 (d, J = 8.6 Hz, 2 H), 3.26–3.14 (m, 2 H), 3.00 (dt,
J = 9.1, 3.3 Hz, 2 H), 2.53–2.36 (m, 2 H), 1.43–1.33 (m, 2 H), 1.30–
1.20 (m, 2 H), 0.90 (t, J = 7.3 Hz, 3 H).
13C NMR (126 MHz, CDCl3): d = 170.3, 144.1, 134.0, 133.3, 130.5,
130.4, 128.3, 123.7, 123.5, 58.3, 55.8, 54.7, 54.5, 53.9, 52.4, 49.9,
45.6, 29.8, 20.2, 14.0.





Yield: 67 mg (83%); yellow oil.
FTIR (thin film): 2951, 2924, 1745, 1329, 1142, 735 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.61 (s, 1H), 7.36–7.28 (m, 3H),
7.23 (d, J = 7.0 Hz, 2H), 7.20–7.12 (m, 4H), 5.50 (s, 2H), 4.89 (d,
J = 15.9 Hz, 1H), 4.49 (d, J = 15.9 Hz, 1H), 4.08 (dd, J = 10.1, 6.9
Hz, 1H), 3.67 (d, J = 13.4 Hz, 1H), 3.59 (d, J = 13.4 Hz, 1H), 3.54
(s, 3H), 3.50 (dd, J = 14.7, 10.1 Hz, 1H), 3.44 (dd, J = 14.7, 6.9 Hz,
1H), 3.24–3.09 (m, 2H), 3.05–2.90 (m, 2H), 2.34 (s, 3H).
13C NMR (126 MHz, CDCl3): d = 170.2, 144.1, 138.8, 138.0, 131.5,
129.8, 128.6, 128.5, 128.1, 127.6, 123.2, 59.2, 58.1, 55.9, 54.5,
54.1, 52.3, 49.1, 45.5, 21.1.





Yield: 55 mg (65%); colorless oil.
FTIR (thin film): 2951, 2833, 1747, 1327, 1142, 737 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.70 (s, 1 H), 7.38–7.24 (m, 8 H),
7.16 (d, J = 7.1 Hz, 1 H), 5.52 (s, 2 H), 4.88 (d, J = 16.0 Hz, 1 H),
4.54 (d, J = 15.9 Hz, 1 H), 4.11 (dd, J = 10.1, 7.0 Hz, 1 H), 3.72 (d,
J = 13.3 Hz, 1 H), 3.64 (d, J = 13.5 Hz, 1 H), 3.56 (s, 3 H), 3.51 (dd,
J = 14.9, 10.2 Hz, 1 H), 3.45 (dd, J = 14.7, 7.0 Hz, 1 H), 3.23–3.12
(m, 2 H), 3.05–2.94 (m, 2 H).
13C NMR (126 MHz, CDCl3): d = 170.1, 144.6, 138.0, 136.5, 135.1,
130.4, 129.0, 128.6, 128.5, 128.0, 127.6, 126.0, 123.5, 59.5, 58.5,
56.0, 54.4, 53.5, 52.4, 49.2, 45.6.
HRMS (TOF MS ES+): m/z calcd for C23H26ClN5O4S + Na (M +
Na)+: 526.1292; found: 526.1281.
Methyl 5-Benzyl-2-{[1-(2-bromobenzyl)-1H-1,2,3-triazol-4-
yl]methyl}-1,2,5-thiadiazepane-3-carboxylate 1,1-Dioxide (7f)
Yield: 69 mg (74%); yellow oil.
FTIR (thin film): 2951, 2841, 1744, 1329, 1142, 737 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.74 (s, 1 H), 7.62 (d, J = 7.8 Hz,
1 H), 7.32 (m, 4 H), 7.25–7.17 (m, 4 H), 5.69 (s, 2 H), 4.93 (d,
J = 15.9 Hz, 1 H), 4.52 (d, J = 15.9 Hz, 1 H), 4.11 (dd, J = 10.1, 6.9
Hz, 1 H), 3.67 (d, J = 13.4 Hz, 1 H), 3.60 (d, J = 13.4 Hz, 1 H), 3.59
(s, 3 H), 3.52 (dd, J = 14.8, 10.2 Hz, 1 H), 3.46 (dd, J = 14.9, 7.1 Hz,
1 H), 3.26–3.11 (m, 2 H), 3.06–2.92 (m, 2 H).
13C NMR (126 MHz, CDCl3): d = 170.2, 144.0, 138.0, 133.9, 133.3,
130.5, 130.4, 128.6, 128.5, 128.2, 127.6, 123.7, 123.5, 59.1, 58.2,
55.9, 54.6, 54.0, 52.4, 49.2, 45.4.
HRMS (TOF MS ES+): m/z calcd for C23H26BrN5O4S + Na (M +




Yield: 58 mg (81%); yellow oil.
FTIR (thin film): 3381, 2951, 2926, 1740, 1329, 1142, 779, 758
cm–1.
1H NMR (400 MHz, acetone-d6): d = 8.00 (s, 1 H), 7.27 (d, J = 7.7
Hz, 2 H), 7.19 (d, J = 7.6 Hz, 2 H), 5.57 (s, 2 H), 4.85 (d, J = 15.9
Hz, 1 H), 4.44 (d, J = 16.0 Hz, 1 H), 4.17 (dd, J = 10.4, 6.9 Hz, 1
H), 3.53 (s, 3 H), 3.50–3.28 (m, 6 H), 3.19–3.04 (m, 2 H), 3.04–2.92
(m, 1 H), 2.52 (s, 2 H), 2.31 (s, 3 H).
13C NMR (126 MHz, acetone-d6): d = 171.2, 144.5, 138.8, 134.0,
130.2, 128.9, 124.6, 60.7, 58.1, 57.3, 57.1, 55.4, 54.0, 52.2, 51.2,
45.8, 21.0.






Yield: 66 mg (87%); yellow oil.
FTIR  (thin film): 3433, 2951, 2928, 1742, 1329, 1142, 777 cm–1.
1H NMR (400 MHz, acetone-d6): d = 8.12 (s, 1 H), 7.45–7.30 (m, 4
H), 5.67 (s, 2 H), 4.86 (d, J = 16.0 Hz, 1 H), 4.47 (d, J = 16.0 Hz, 1
H), 4.20 (dd, J = 10.4, 7.0 Hz, 1 H), 3.56 (s, 3 H), 3.52–3.42 (m, 4
H), 3.40–3.32 (m, 1 H), 3.20–3.05 (m, 2 H), 3.03–2.94 (m, 1 H),
2.56 (t, J = 4.8 Hz, 2 H), 2.09 (s, 1 H).
13C NMR (126 MHz, acetone-d6): d = 171.2, 144.7, 139.3, 134.9,
131.4, 129.1, 128.8, 127.4, 125.0, 60.7, 58.3, 57.5, 57.1, 55.4, 53.4,
52.2, 51.2, 45.8.
HRMS (TOF MS ES+): m/z calcd for C18H24ClN5O5S + Na (M +




Yield: 62 mg (73%); yellow oil.
FTIR (thin film): 3385, 2926, 2930, 1734, 1327, 1142, 760 cm–1.
1H NMR (400 MHz, acetone-d6): d = 8.08 (s, 1 H), 7.68 (d, J = 8.5
Hz, 1 H), 7.41 (t, J = 7.4 Hz, 1 H), 7.32 (dd, J = 10.4, 4.7 Hz, 1 H),
7.22 (d, J = 7.5 Hz, 1 H), 5.74 (s, 2 H), 4.89 (d, J = 16.0 Hz, 1 H),
4.48 (d, J = 15.9 Hz, 1 H), 4.26–4.15 (m, 1 H), 3.59 (s, 3 H), 3.56–
3.35 (m, 6 H), 3.18–3.09 (m, 2 H), 3.03–2.96 (m, 1 H), 2.56 (s, 2 H).
13C NMR (126 MHz, acetone-d6): d = 171.2, 136.0, 133.9, 131.2,
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HRMS (TOF MS ES+): m/z calcd for C18H24BrN5O5S + Na (M +
Na)+: 524.0579; found: 524.0587.
Supporting Information for this article is available online at
http://www.thieme-connect.com/ejournals/toc/synthesis.
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